A pioneering technology

Accure Is Here.

At Accure, we are wholly committed to developing revolutionary solutions to address acne. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.

about accure

Committed to Science and Safety

  • Clinical Trials

    • Over 6 IRB-approved trials with 100+ subjects treated

    • Face Trials

    • Back Trials

    • Focal Treatments

    • Split-Face Treatments

    • Mid/Lower Face Treatments

    • All Fitzpatrick Skin Types

  • Safety

    • Over 50,000 trigger pulls (1 trigger pull = 6 pulses) performed with no unexpected adverse events

    • Device designed to only deliver to Peak Epidermal Temperature (PET) target, with auto shut-off if temperature approaches safety limit. (pat. protected.)

doctor

The Accure Laser deploys real-time machine learning capability to assess and optimize the laser-tissue-temperature balance to deliver safe and efficacious treatments.

Henrik Hofvander, CTO
clinical response

A Significant Clinical Response

  • Treatment regimen will be customized to the individual patient and could range from 1 to 6 treatment sessions administered approximately 3 to 6 weeks apart.

  • This clinical study treatment regimen consists of a total of four treatment sessions, each approximately 4 weeks apart. These subjects were part of an IRB-approved pilot study with a specific treatment area as noted in the photos.

Explore the results

before treatment before 1

January 2019

after treatment after 1

August 6, 2020, Month Follow-up

before treatment before 1

Pre-Treatment

after treatment after 2

After 4 Treatments

before treatment before 3

April 2019

after treatment after 3

October 12, 2019, 6 Month Follow-up

before treatment before 4

December 2, 2020

after treatment after 4

May 29, 2021 - 1 Month Follow-up

prev
next
tech
accure laser

A Pioneering Technology

A truly differentiated and protected product for clinicians worldwide

The Accure Laser has been granted both CE Mark approval and FDA clearance for the treatment of inflammatory acne vulgaris.

  • Treat-To-Temperature: A Paradigm Change

    A closed-loop system that uses an advanced, predictive thermal monitoring and modulation platform to target and thermally damage sebaceous glands.

  • Easy To Use

    Provides an elegant and simple interface for providers and their extenders to deliver safe, consistent, and reproducible treatments.

Order Your Laser Now
key information

The Accure First Program

  • Board-certified dermatologists and dermatology practices to order their laser will be the among the first clinicians in the world to own the Accure Laser.

  • Customer must be a board-certified dermatologist or a practice owner/operator that employs board-certified dermatologists at the practice.

  • We are making a limited number of devices available.

  • 10% deposit is required to secure device and confirm delivery schedule.

  • Package includes The Accure Laser, multi-year warranty, and free consumables.

  • Delivery is expected in the Q4 timeframe.

  • Customer must execute Purchase Agreement, End-User Agreement, and complete payment for 10% deposit

  • There is no restrictive condition or covenant for using/purchasing similar products and devices.

Truly Differentiated And Protected Product For Clinicians Worldwide

We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.

Order Your Laser Now